Treace to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023
27. Februar 2023 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of...
Treace Presents Updated ALIGN3D™ Interim Data and Latest Product Innovations at the 2023 ACFAS Annual Conference
09. Februar 2023 13:00 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of...
Treace Medical Concepts, Inc. Announces Pricing of $100.0 Million Public Offering of Common Stock
07. Februar 2023 21:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of...
Treace Medical Concepts, Inc. Announces Proposed Public Offering of Common Stock
07. Februar 2023 16:30 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of...
Treace Medical Concepts Provides 2022 Preliminary Unaudited Revenue
09. Januar 2023 08:00 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace to Present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023
20. Dezember 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Medical Announces Expansion of Its Global IP Portfolio with the Grant of Two New U.S. Patents
19. Dezember 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in...
Treace Receives FDA 510(k) Clearance for SpeedPlate™ Rapid Compression Implant Technology
28. November 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Announces First Patient Treated in MTA3D™ Adductoplasty® Clinical Study
21. November 2022 16:15 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of...
Treace Medical Concepts Reports Third Quarter 2022 Financial Results
08. November 2022 16:05 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...